Navigation Links
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Date:2/7/2008

ar(R). He brings comprehensive perspective with more than 15 years experience at Wyeth, Sanofi-Pasteur and Philom Bios in global vaccine and bio/pharmaceutical process and product development, manufacturing operations and quality assurance. Dr. Chao earned his doctorate and completed his postdoctoral fellowship at the Industrial Biotechnology Center, University of Waterloo, Ontario, Canada.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases; cancer; inflammatory diseases; cardiovascular and metabolic diseases; pain and central nervous system disorders and gastrointestinal diseases. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. MedImmune Submits Biologics License Application to FDA for Motavizumab
2. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
3. MedImmune Announces Seven Key Promotions and New Hires
4. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
5. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
6. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
7. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
8. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
9. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
10. Anavex strengthens Board of Directors
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...LTHAM, Mass., Dec. 2 Decision Biom...ker analysis systems for pharmaceutical research,...a Scientific Advisory Board,consisting of interna...,forefront of biomarker and clinical research. Th... Daniel W. Chan, Ph.D., Director of the Center for...
(Date:12/2/2008)...AHA, Neb. and HOUSTON, Dec. 2 /PRNewswire-FirstCal...O) and Power3 Medical Products, Inc. (OTC,Bulleti...as signed a letter of,intent to acquire exclusive...omarkers, which include NuroPro(R), a proposed dia... Transgenomic plans to offer NuroPro(R) in its,CL...
(Date:12/2/2008)...OTTSDALE, Ariz., Dec. 2 MedPredict...ical competitive intelligence and market,research...rategic insight for,pharma and biotech companies ...e (PD) therapies. This report, entitled Thought L...se, is based on 9 interviews conducted with PD,ex...
(Date:12/2/2008)...LENCIA, Calif., Dec. 2 The Alfred ...MFBE), a philanthropic organization created by,bi...ased commercialization-,enablement institutes at ...cal,product development for the benefit of societ...p://www.mannfbe.org ). , Features of the we...
Breaking Biology Technology:Decision Biomarkers Inc Announces Formation of Scientific Advisory Board 2Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 2Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 3Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 4New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market 2
..., , , Katrin Ravenschlag , M...usstr.1, 28359 Germany , Phone: ++49-421-20...i-bremen.de , , Introduction ,...r sediments always results , in coextract...r other , humic substances, which negativ...
..., , , Christian Rohrer and Lars-Erik Pe...any , Lars-Erik Peters, Eppendorf 5Prime, U...e reliability of a PCR* experiment is dependent on...ducibility. An essential prerequisite for a succes...n, as well as thermal cyclers with excellent , ...
..., , , Multiporator , , , ,... Transfection Protocol , Protocol No...., , , , , , , , ... human leukemic monoblasts, , ,...d pEGFP-N1 (in bidistilled H 2 O), , ...
..., , , Multiporator / Electroporator 251..., , Transformation Protocol ,..., , , , , , , ,...croorganism , Staphylococcus epidermidi..., Bacteria, gram positive, , ...
Other Biology Technology:The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 2The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 3The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 4The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7U937 2Staphylococcus epidermidis 2
(Date:12/2/2008)...ber 16, 2008 In a study in the advance online edi... researchers from Albert Einstein College of Medic...ly at a fundamental step of a cell,s life a gene,...ue could provide a window into the process by whic...isease. , The new technique provides a detailed...
(Date:12/2/2008)... release is available in French . , Plant r...ty of California, Berkeley, have announced a major...igenetics. They have demonstrated for the first ti...cing in plants. , The findings are important to... in the continuing quest to breed enhanced crops t...
(Date:12/2/2008)...ST LAFAYETTE, Ind. - Researchers at Purdue Univers...nd holograms to precisely position numerous tiny p...new tool to analyze biological samples or create d...ed rapid electrokinetic patterning, is a potential...patterns can be more quickly and easily changed, s...
(Date:12/2/2008)...ON, Dec. 2, 2008 Scientists and engineers from tw... energy will come together Dec. 8, along with aca...re synergies in moving oil and pumping blood. ,...rt must pump blood through the body. Both systems...els), free of blockages or corrosion, to function ...
Breaking Biology News(10 mins):Einstein researchers develop technique to count messages made by single genes 2Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3New holographic method could be used for lab-on-a-chip technologies 2New holographic method could be used for lab-on-a-chip technologies 3New holographic method could be used for lab-on-a-chip technologies 4Using the other guy's toolkit: Similarities of pumping blood, oil examined 2Pharmion Corporation to Announce Third Quarter 2007 Financial Results 1357 1Pharmion Corporation to Announce Third Quarter 2007 Financial Results 1357 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 3Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2 572 1Congressional failure to override SCHIP veto saddens physicians 4098 1Congressional failure to override SCHIP veto saddens physicians 4098 2
...approach animals in the wild more easily from a ca...tor" tuned to the visual movements of an approachi...logist Niko Troje. , "We believe this visual filt...are propelled by the motion of their feet and the ...arch Chair in Vision and Behavioural Sciences. ,...
...h at the University of Illinois atUrbana-Champaign...irst sequence of the swine genome to be completed ... the U.S. Department of Agriculture announced toda... , Lawrence B. Schook, a professor of animal scien...al Swine Genome Sequencing Consortium, will head t...
...stainable agricultural production, what is require...es to the nitrates that predominate in agricultura...ty. The current use of nitrates as a nitrogenated ...environmental problems such as the contamination o...re are also health problems such as deficiencies i...
... is not associated with an increased risk of cance...ue of the Journal of the National Cancer Institu...breast cancer risk and an increased lung cancer ri...s and smoking habits of the women in the study rat... authors conclude. , Past reports have examined th...
Other Biology News:Animal brains 'hard-wired' to recognize predator's foot movements, Queen's study suggests 2Illinois pig to make history as source of first complete swine genome 2Alternatives to the use of nitrate as a fertiliser 2Alternatives to the use of nitrate as a fertiliser 3Breast implants not associated with cancer risk, study reports 2
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C
TUP1 Market Segment: Molecular Biology
UbcH7 interacts with the HECT protein, E6-AP and the c-Cbl RING domain. Evidence suggests that this E2 is involved in both the degradation of non-""N-end rule"" protein substrates and of certain N-a
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody
Biology Products: